Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Gross Margin (2016 - 2026)

Angiodynamics' Gross Margin history spans 17 years, with the latest figure at 52.89% for Q1 2026.

  • For Q1 2026, Gross Margin fell 107.0% year-over-year to 52.89%; the TTM value through Feb 2026 reached 54.3%, down 6.0%, while the annual FY2025 figure was 53.92%, 301.0% up from the prior year.
  • Gross Margin reached 52.89% in Q1 2026 per ANGO's latest filing, down from 56.38% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 56.38% in Q4 2025 to a low of 47.7% in Q1 2024.
  • Average Gross Margin over 5 years is 52.67%, with a median of 52.77% recorded in 2022.
  • Peak YoY movement for Gross Margin: plummeted -250bps in 2023, then surged 627bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 52.77% in 2022, then fell by -4bps to 50.92% in 2023, then increased by 8bps to 54.78% in 2024, then increased by 3bps to 56.38% in 2025, then fell by -6bps to 52.89% in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Gross Margin are 52.89% (Q1 2026), 56.38% (Q4 2025), and 55.29% (Q3 2025).